Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsVIALStandard

ONCASPAR

PEGASPARGASE

Standard Dose
750IU/VIAL
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview ONCASPAR is listed in Drugs@FDA under application 103411 (BLA).

Review priority: STANDARD Marketing status: Prescription Active ingredient PEGASPARGASE Form and strength VIAL - 750IU/VIAL Sponsor SIGMA TAU Submission history Latest submission status date: 2024-03-13 00:00:00.

Structured Monograph

Clinical summary

Approval overview ONCASPAR is listed in Drugs@FDA under application 103411 (BLA). Review priority: STANDARD Marketing status: Prescription Active ingredient PEGASPARGASE Form and strength VIAL - 750IU/VIAL Sponsor SIGMA TAU Submission history Latest submission status date: 2024-03-13 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.